Sumitomo Mitsui Trust Group’s Standard BioTools LAB Stock Holding History

Sumitomo Mitsui Trust Group’s Portfolio LAB Stock Details LAB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$339K	Sell	412,288 -30,496	-7%	-$28.8K	﹤0.01%	1018
2026 Q1	$407K	Sell	442,784 -3,893,103	-90%	-$4.71M	﹤0.01%	960
2025 Q4	$5.55M	Sell	4,335,887 -1,055,942	-20%	-$1.42M	﹤0.01%	723
2025 Q3	$7.01M	Sell	5,391,829 -773,708	-13%	-$1.01M	﹤0.01%	707
2025 Q2	$7.4M	Sell	6,165,537 -68,156	-1%	-$75.6K	﹤0.01%	691
2025 Q1	$6.73M	Sell	6,233,693 -384,701	-6%	-$540K	﹤0.01%	715
2024 Q4	$11.6M	Sell	6,618,394 -2,960,169	-31%	-$5.51M	0.01%	696
2024 Q3	$18.5M	Sell	9,578,563 -1,063,708	-10%	-$2.08M	0.01%	656
2024 Q2	$18.8M	Buy	10,642,271 +1,788,780	+20%	+$4.37M	0.01%	643
2024 Q1	$24M	Buy	+8,853,491	New	+$21.4M	0.02%	677

Other funds holding LAB

PLC

Peapod Lane Capital Bedford Hills, New York $148M AUM 89.92% 1-Year Est. Return

MAM

Marquette Asset Management Minneapolis, Minnesota $779M AUM 23.4% 1-Year Est. Return

YIH

Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

EWA

EverSource Wealth Advisors Birmingham, Alabama $2.97B AUM 28.74% 1-Year Est. Return

PTP

Platform Technology Partners New York $611M AUM 25.5% 1-Year Est. Return

MFG

Merit Financial Group Alpharetta, Georgia $16.4B AUM 25.17% 1-Year Est. Return

EWA

Evolution Wealth Advisors Aventura, Florida $855M AUM 27.24% 1-Year Est. Return

VWA

VSM Wealth Advisory Hunt Valley, Maryland $376M AUM 21.56% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Sumitomo Mitsui Trust Group's LAB Position: Q2 2026 in Review

Sumitomo Mitsui Trust Group reduced its Standard BioTools (LAB) stake by 6.9% in Q2 2026, selling an estimated $28.8K and leaving 412,288 shares worth $339K. The position accounts for ﹤0.01% of the portfolio, ranked #1018.

Sumitomo Mitsui Trust Group first reported a position in LAB in Q1 2024 and has held it in 10 quarters since. The position peaked at $24M in Q1 2024. 18 funds tracked by Wall St. Rank hold LAB as of Q2 2026.

Sumitomo Mitsui Trust Group held 412,288 shares of Standard BioTools worth $339K as of Q2 2026.
Sumitomo Mitsui Trust Group sold 30,496 Standard BioTools shares in Q2 2026, an estimated $28.8K.
Standard BioTools made up ﹤0.01% of Sumitomo Mitsui Trust Group's portfolio in Q2 2026, its #1018 holding.
Sumitomo Mitsui Trust Group first reported a position in Standard BioTools in Q1 2024 and has held it in 10 quarters since.
Sumitomo Mitsui Trust Group's Standard BioTools position peaked at $24M in Q1 2024.
18 funds tracked by Wall St. Rank held Standard BioTools as of Q2 2026.

Based on Sumitomo Mitsui Trust Group's 13F filing for Q2 2026, filed 30 Jul 2026.